Quick Dispatch:
Your foxo4-dri peptide senolytic study The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your foxo4-dri peptide senolytic study The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI ships.
Need Help?
Questions about foxo4-dri peptide senolytic study The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for foxo4-dri peptide senolytic study The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI in your area.
FOXO4-DRI
22.77
FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation
21.77
FOXO4-DRI For Sale (10mg)
26.15
Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells
28.73
Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells
22.68
(PDF) Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes
29.66
foxo4-dri senolytic peptide human trial 2024 Buy Epithalon (50mg) | 99% Purity
24.06
